Literature DB >> 20836552

Cardiac contractile dysfunction and apoptosis in streptozotocin-induced diabetic rats are ameliorated by garlic oil supplementation.

Hsiu-Chung Ou1, Bor-Show Tzang, Mu-Hsin Chang, Cheng-Tzu Liu, Hui Wen Liu, Chong-Kuei Lii, Da-Tian Bau, Pei-Min Chao, Wei-Wen Kuo.   

Abstract

Previous studies have suggested that garlic oil could protect the cardiovascular system. However, the mechanism by which garlic oil protects diabetes-induced cardiomyopathy is unclear. In this study, streptozotocin (STZ)-induced diabetic rats received garlic oil (0, 10, 50, or 100 mg/kg of body weight) by gastric gavage every 2 days for 16 days. Normal rats without diabetes were used as control. Cardiac contractile dysfunction examined by echocardiography and apoptosis evaluated by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay were observed in diabetic rat hearts. Additionally, a shift in cardiac myosin heavy chain (MHC) gene expression from α- to β-MHC isoform, decreased levels of superoxide dismutase-1 (SOD-1) and cardiac α-actin, and elevated cardiac thiobarbituric acid reactive substances (TBARS) and caspase- and p38-NFκB-leading apoptosis signaling activities were demonstrated in diabetic hearts. However, these diabetes-related cardiac dysfunctions were almost dose-dependently ameliorated by garlic oil administration. In conclusion, garlic oil possesses significant potential for protecting hearts from diabetes-induced cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20836552     DOI: 10.1021/jf101606s

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  8 in total

Review 1.  Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications.

Authors:  Csaba Szabo
Journal:  Antioxid Redox Signal       Date:  2012-01-30       Impact factor: 8.401

2.  The Antidiabetic Effect of Garlic Oil is Associated with Ameliorated Oxidative Stress but Not Ameliorated Level of Pro-inflammatory Cytokines in Skeletal Muscle of Streptozotocin-induced Diabetic Rats.

Authors:  Cheng-Tzu Liu; Tien-Wei Hsu; Ke-Ming Chen; Ya-Ping Tan; Chong-Kuei Lii; Lee-Yan Sheen
Journal:  J Tradit Complement Med       Date:  2012-04

3.  Lipolysis stimulating peptides of potato protein hydrolysate effectively suppresses high-fat-diet-induced hepatocyte apoptosis and fibrosis in aging rats.

Authors:  Wen-Dee Chiang; Chih Yang Huang; Catherine Reena Paul; Zong-Yan Lee; Wan-Teng Lin
Journal:  Food Nutr Res       Date:  2016-07-12       Impact factor: 3.894

4.  Diallyl trisulfide exerts cardioprotection against myocardial ischemia-reperfusion injury in diabetic state, role of AMPK-mediated AKT/GSK-3β/HIF-1α activation.

Authors:  Liming Yu; Wencheng Di; Xue Dong; Zhi Li; Xiaodong Xue; Jian Zhang; Qi Wang; Xiong Xiao; Jinsong Han; Yang Yang; Huishan Wang
Journal:  Oncotarget       Date:  2017-08-24

5.  Pkcδ Activation is Involved in ROS-Mediated Mitochondrial Dysfunction and Apoptosis in Cardiomyocytes Exposed to Advanced Glycation End Products (Ages).

Authors:  Chih-Yang Huang; Wei-Wen Kuo; Yao-Chih Yang; Cheng-Yen Tsai; Chien-Lin Chen; Chia-Hua Kuo; Chien-Wen Hou; Shi-Yann Cheng; Ritu Aneja
Journal:  Aging Dis       Date:  2018-08-01       Impact factor: 6.745

6.  Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats.

Authors:  Hong Li; Yunfei Bian; Nana Zhang; Jia Guo; Cheng Wang; Wayne Bond Lau; Chuanshi Xiao
Journal:  Cardiovasc Diabetol       Date:  2013-06-18       Impact factor: 9.951

Review 7.  A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes.

Authors:  Emily J Cox; Susan A Marsh
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

8.  Diallyl Trisulfide (DATS) Suppresses AGE-Induced Cardiomyocyte Apoptosis by Targeting ROS-Mediated PKCδ Activation.

Authors:  Dennis Jine-Yuan Hsieh; Shang-Chuan Ng; Ren-You Zeng; Viswanadha Vijaya Padma; Chih-Yang Huang; Wei-Wen Kuo
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.